Formulation and Evaluation of a Silymarin Inclusion Complex-Based Gel for Skin Cancer

Overview

Journal ACS Omega

Publisher American Chemical Society

Date 2025 Feb 3

PMID 39895738

Authors

Wael A Mahdi

Syed Sarim Imam

Abdulkarim Alotaibi

Saad Alhallaf

Riyad F Alzhrani

Sultan Alshehri

Affiliations

Soon will be listed here.

Abstract

Silymarin (SLM) is a bioactive, water-insoluble flavonoid reported against different types of cancer. In the present research, the SLM inclusion complex was prepared by the freeze-drying method using different cyclodextrins. The phase solubility study was performed to assess the stability constant and complexation efficiency. The prepared SLM inclusion complexes (F1, F2, and F3) were characterized for different physicochemical and in vitro parameters. Based on the results, the selected inclusion complex (F2) was converted to a topical gel. Finally, it was evaluated for antioxidant, protein denaturation, and cell viability assay (B16F10; skin cancer cell line). The in vitro results were further confirmed by performing a molecular docking study. The phase solubilization results showed the formation of a stable complex with a stability constant value of 548 mol L (βCD-PLX), 911 mol L (HP βCD-PLX), and 736 mol L (M βCD-PLX). A marked increase in release pattern was found from the prepared inclusion complex (80.9 ± 2.2-97.8 ± 3.1%) compared to free SLM (24.1 ± 2.8%). DSC as well as the IR studies confirm the formation of a stable complex. SEM and X-ray diffraction results confirmed the conversion to the amorphous form. The molecular docking studies exhibited the high docking score of SLM with both colchicine-binding sites of the tubulin protein (-6.28 kcal/mol) and complexing agents, viz., βCD (-4.61 kcal/mol), HP βCD (-5.77 kcal/mol), and M βCD (-5.61 kcal/mol). The antioxidant assay results showed that the activity was significantly improved (1.2-1.6 fold) compared to free SLM. The in vitro cell viability assay outcome displayed concentration-dependent activity with a significantly lower IC50 value from F2G2 (145.3 ± 4.2 μg/mL) than free SLM (304.7 ± 5.7 μg/mL). The above conclusions demonstrated that the developed SLM inclusion complex-based gel system could be an ideal delivery system for skin cancer.

References

Saffarionpour S, Diosady L . Preparation and characterization of an iron-β-cyclodextrin inclusion complex: factors influencing the host-guest interaction. Food Funct. 2023; 14(11):5062-5077. DOI: 10.1039/d3fo00090g. View

Imam S, Gilani S, Zafar A, Bin Jumah M, Alshehri S . Formulation of Miconazole-Loaded Chitosan-Carbopol Vesicular Gel: Optimization to In Vitro Characterization, Irritation, and Antifungal Assessment. Pharmaceutics. 2023; 15(2). PMC: 9959533. DOI: 10.3390/pharmaceutics15020581. View

Gunathilake K, Ranaweera K, Rupasinghe H . In Vitro Anti-Inflammatory Properties of Selected Green Leafy Vegetables. Biomedicines. 2018; 6(4). PMC: 6316011. DOI: 10.3390/biomedicines6040107. View

Lian R, Lu Y, Qi J, Tan Y, Niu M, Guan P . Silymarin glyceryl monooleate/poloxamer 407 liquid crystalline matrices: physical characterization and enhanced oral bioavailability. AAPS PharmSciTech. 2011; 12(4):1234-40. PMC: 3225519. DOI: 10.1208/s12249-011-9666-2. View

Yang K, Hwang D, Mehmood Yousaf A, Kim D, Shin Y, Bae O . Silymarin-loaded solid nanoparticles provide excellent hepatic protection: physicochemical characterization and in vivo evaluation. Int J Nanomedicine. 2013; 8:3333-43. PMC: 3770518. DOI: 10.2147/IJN.S50683. View

Petraskova L, Kanova K, Biedermann D, Kren V, Valentova K . Simple and Rapid HPLC Separation and Quantification of Flavonoid, Flavonolignans, and 2,3-Dehydroflavonolignans in Silymarin. Foods. 2020; 9(2). PMC: 7073671. DOI: 10.3390/foods9020116. View

Donthiboina K, Anchi P, Gurram S, Mani G, Uppu J, Godugu C . Synthesis and biological evaluation of substituted N-(2-(1H-benzo[d]imidazol-2-yl)phenyl)cinnamides as tubulin polymerization inhibitors. Bioorg Chem. 2020; 103:104191. DOI: 10.1016/j.bioorg.2020.104191. View

Peram M, Jalalpure S, Kumbar V, Patil S, Joshi S, Bhat K . Factorial design based curcumin ethosomal nanocarriers for the skin cancer delivery: evaluation. J Liposome Res. 2018; 29(3):291-311. DOI: 10.1080/08982104.2018.1556292. View

Haley R, Gottardi R, Langer R, Mitchell M . Cyclodextrins in drug delivery: applications in gene and combination therapy. Drug Deliv Transl Res. 2020; 10(3):661-677. PMC: 7524011. DOI: 10.1007/s13346-020-00724-5. View

10.

Naeem A, Yu C, Zhu W, Zang Z, Guan Y . Study of Hydroxypropyl β-Cyclodextrin and Puerarin Inclusion Complexes Encapsulated in Sodium Alginate-Grafted 2-Acrylamido-2-Methyl-1-Propane Sulfonic Acid Hydrogels for Oral Controlled Drug Delivery. Gels. 2023; 9(3). PMC: 10048200. DOI: 10.3390/gels9030246. View

11.

Shankar V, Police A, Ajjarapu S, Murthy S . Development of silymarin topical formulation: In vitro and ex vivo dermal kinetics of silymarin. Int J Pharm. 2022; 630:122431. DOI: 10.1016/j.ijpharm.2022.122431. View

12.

Zeng Q, Liu Z, Huang A, Zhang J, Song H . Preparation and characterization of silymarin synchronized-release microporous osmotic pump tablets. Drug Des Devel Ther. 2016; 10:519-31. PMC: 4743634. DOI: 10.2147/DDDT.S91571. View

13.

Dai K, Wu J, Liu X, Wang S, Liu Y, Li H . Inclusion complex of quercetin with sulfobutylether β-cyclodextrin: preparation, characterization, antioxidant and antibacterial activities and the inclusion mechanism. RSC Adv. 2024; 14(14):9472-9481. PMC: 10951979. DOI: 10.1039/d3ra08936c. View

14.

Iqbal B, Ali J, Ganguli M, Mishra S, Baboota S . Silymarin-loaded nanostructured lipid carrier gel for the treatment of skin cancer. Nanomedicine (Lond). 2019; 14(9):1077-1093. DOI: 10.2217/nnm-2018-0235. View

15.

Mehmood Yousaf A, Malik U, Shahzad Y, Mahmood T, Hussain T . Silymarin-laden PVP-PEG polymeric composite for enhanced aqueous solubility and dissolution rate: Preparation and in vitro characterization. J Pharm Anal. 2019; 9(1):34-39. PMC: 6355470. DOI: 10.1016/j.jpha.2018.09.003. View

16.

Zheng Y, Ouyang W, Wei Y, Syed S, Hao C, Wang B . Effects of Carbopol 934 proportion on nanoemulsion gel for topical and transdermal drug delivery: a skin permeation study. Int J Nanomedicine. 2016; 11:5971-5987. PMC: 5108606. DOI: 10.2147/IJN.S119286. View

17.

Katiyar S . Silymarin and skin cancer prevention: anti-inflammatory, antioxidant and immunomodulatory effects (Review). Int J Oncol. 2004; 26(1):169-76. View

18.

Montecinos F, Sackett D . Structural Changes, Biological Consequences, and Repurposing of Colchicine Site Ligands. Biomolecules. 2023; 13(5). PMC: 10216767. DOI: 10.3390/biom13050834. View

19.

Imam S, Alshehri S, Altamimi M, Mahdi W, Qamar W . Formulation of Silymarin-β Cyclodextrin-TPGS Inclusion Complex: Physicochemical Characterization, Molecular Docking, and Cell Viability Assessment against Breast Cancer Cell Lines. ACS Omega. 2023; 8(38):34898-34907. PMC: 10536084. DOI: 10.1021/acsomega.3c04225. View

20.

Wang Y, Deng Z, Wang X, Shi Y, Lu Y, Fang S . Formononetin/methyl-β-cyclodextrin inclusion complex incorporated into electrospun polyvinyl-alcohol nanofibers: Enhanced water solubility and oral fast-dissolving property. Int J Pharm. 2021; 603:120696. DOI: 10.1016/j.ijpharm.2021.120696. View